Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Shattock: Novel Antigens for Mucosal Protection |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Rabbit |
| Stage: | Assays Completed |
| Study Start Date: | 2009-04-02 |
| Study Made Public: | 2013-04-30 |
Title
Shattock_Cole_ZM96_2
Description
CAVD 242 is a preclinical rabbit study comparing several recombinant clade C HIV gp140/adjuvant regimens in which the antigen was attached to microparticles in an effort to expose different epitopes.
Sign in to see full information about this study and to download study data.
Products
Gel MF59 ZM96 gp140 Wax particles PLA particlesIntegrated data
NAb
Non-integrated data
No non-integrated data is available for this study.